<DOC>
	<DOCNO>NCT00728689</DOCNO>
	<brief_summary>The purpose study evaluate pharmacokinetic parameter safety single dose ST-246 400mg Form I versus ST-246 400mg Form V capsule feed normal healthy volunteer .</brief_summary>
	<brief_title>Phase I Trial Investigational Small Pox Medication</brief_title>
	<detailed_description>This Phase I , double-blind , cross-over , single-dose study orally administer anti-orthopoxvirus compound , ST-246 , 12 healthy , fed volunteer age 18 50 year . Subjects randomize 6 subject receive either ST-246 Form I ( monohydrate ) follow 10 day later wash-out period Form V ( hemihydrate ) , 6 subject receive ST-246 Form V follow Form I , previous group . Both form ST-246 similar way manufacture . The difference Form I Form V may relate dissolve , may affect way absorbed human body . Information side-effects may occur also collect study .</detailed_description>
	<mesh_term>Smallpox</mesh_term>
	<mesh_term>Monkeypox</mesh_term>
	<criteria>1 . 18 50 year 2 . Available clinical followup duration study . 3 . Able/willing give write consent . 4 . Good general health ; clinically significant medical history . 5 . Refrain take medication screen 72 hour last dose . 6 . Adequate venous access . 7 . PE lab result without clinically significant finding within 28 day prior receipt drug . 8 . Meet Lab Criteria within 28 day prior receipt drug . 9 . Negative pregnancy test 10 . Non smokers 11 . No alcohol caffeine 12 . Participant partner undergone surgical sterilization , participant agree either abstinent use two nonhormonal method contraception duration study 1 . Marked baseline prolongation QT/corrected QT interval ( QTc ) interval ( 2 . History additional risk factor Torsade de Pointes 3 . Clinically significant abnormal ECG 4 . Personal history cardiac disease , symptomatic asymptomatic arrhythmia , syncopal episode , prolongation PR interval 5 . Family history Sudden Cardiac Death clearly due acute myocardial infarction . 6 . History clinically significant condition include : Asthma Diabetes mellitus History thyroidectomy thyroid disease Serious angioedema episode Head trauma result diagnosis TBI concussion Seizure history seizure Bleeding disorder diagnose doctor significant bruising bleed difficulty intramuscular injection blood draw Malignancy 7 . Family history idiopathic seizures 8 . History presence neutropenia blood dyscrasia 9 . Known Hepatitis B Hepatitis C infection 10 . Known human immunodeficiency virus ( HIV ) acquire immunodeficiency syndrome illness . 11 . Current recent history clinically significant bacterial , fungal , mycobacterial infection . 12 . Known clinically significant chronic viral infection ( current clinically significant viral infection 13 . History frequent severe headache migraine 14 . Known chronic bacterial , mycobacterial , fungal , parasitic , protozoal infection 15 . Woman pregnant breastfeeding planning become pregnant 16 . On concomitant medication 17 . History drug allergy , opinion PI , contraindicate participation trial . 18 . Inability swallow medication 19 . Body Mass Index 35 18 , 20 . Current drug abuse alcohol abuse . 21 . Inability refrain physical exercise period 24 hr PK day refrain consume xanthine , grapefruit grapefruit juice 22 . Clinically significant lactose intolerance 23 . Received experimental drug within 30 day 24 . Vaccination within 30 day 25 . Total 350 milliliter ( mL ) blood drawn 2 month 26 . Treatment immunosuppressant immunomodulatory medication 3 month 27 . Any condition occupational reason responsibility , judgment PI , would jeopardize safety right subject participate trial would render subject unable comply protocol 28 . History diagnosis would affect absorption study medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>Orthopoxviral</keyword>
	<keyword>Smallpox</keyword>
	<keyword>Monkey pox</keyword>
</DOC>